Follow
Kedar V. Inamdar, M.D., Ph.D.
Kedar V. Inamdar, M.D., Ph.D.
Division Head Hematopathology, Henry Ford Hospital
Verified email at hfhs.org
Title
Cited by
Cited by
Year
Conversion of phosphoglycolate to phosphate termini on 3′ overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1
KV Inamdar, JJ Pouliot, T Zhou, SP Lees-Miller, A Rasouli-Nia, LF Povirk
Journal of Biological Chemistry 277 (30), 27162-27168, 2002
2342002
Accurate in vitro end joining of a DNA double strand break with partially cohesive 3′-overhangs and 3′-phosphoglycolate termini: effect of Ku on repair fidelity
S Chen, KV Inamdar, P Pfeiffer, E Feldmann, MF Hannah, Y Yu, JW Lee, ...
Journal of Biological Chemistry 276 (26), 24323-24330, 2001
1322001
Pathology of chronic lymphocytic leukemia: an update
KV Inamdar, CE Bueso-Ramos
Annals of diagnostic pathology 11 (5), 363-389, 2007
1212007
A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
T Velusamy, MJ Kiel, AA Sahasrabuddhe, D Rolland, CA Dixon, ...
Blood, The Journal of the American Society of Hematology 124 (25), 3768-3771, 2014
1032014
High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia
SN Konoplev, HA Fritsche, S O’Brien, WG Wierda, MJ Keating, TG Gornet, ...
American journal of clinical pathology 134 (3), 472-477, 2010
652010
Bone marrow involvement by marginal zone B-cell lymphomas of different types
KV Inamdar, LJ Medeiros, JL Jorgensen, HM Amin, EJ Schlette
American journal of clinical pathology 129 (5), 714-722, 2008
512008
Colony-stimulating factor 1 receptor (CSF1R) activates AKT/mTOR signaling and promotes T-cell lymphoma viability
C Murga-Zamalloa, DCM Rolland, A Polk, A Wolfe, H Dewar, ...
Clinical Cancer Research 26 (3), 690-703, 2020
492020
The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma
ME Salama, M Rajan Mariappan, K Inamdar, SR Tripp, SL Perkins
International journal of surgical pathology 18 (2), 121-128, 2010
472010
Prognostic impact of tumor microenvironment in diffuse large B-cell lymphoma uniformly treated with R-CHOP chemotherapy
JC Gomez-Gelvez, ME Salama, SL Perkins, M Leavitt, KV Inamdar
American journal of clinical pathology 145 (4), 514-523, 2016
452016
Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3−/dimCD4+ population by flow cytometry: An important clue to the diagnosis of a …
M Alikhan, JY Song, AR Sohani, J Moroch, A Plonquet, AS Duffield, ...
Modern Pathology 29 (10), 1173-1182, 2016
382016
Proliferation predicts failure‐free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and …
M Garcia, JE Romaguera, KV Inamdar, GZ Rassidakis, LJ Medeiros
Cancer: Interdisciplinary International Journal of the American Cancer …, 2009
362009
Differential expression of aurora-A kinase in T-cell lymphomas
R Kanagal-Shamanna, NL Lehman, JP O'donnell, MS Lim, DS Schultz, ...
Modern Pathology 26 (5), 640-647, 2013
342013
Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper‐CVAD and rituximab, alternating with rituximab …
KV Inamdar, JE Romaguera, E Drakos, RJ Knoblock, M Garcia, ...
Cancer 115 (20), 4727-4736, 2009
262009
Resistance of 3′-phosphoglycolate DNA ends to digestion by mammalian DNase III
KV Inamdar, Y Yu, LF Povirk
Radiation research 157 (3), 306-311, 2002
212002
GATA3 immunohistochemical staining in Hodgkin lymphoma: diagnostic utility in differentiating classic Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and …
B Kezlarian, M Alhyari, G Venkataraman, K Karner, KV Inamdar, ...
Applied Immunohistochemistry & Molecular Morphology 27 (3), 180-184, 2019
202019
Cystic tumor of the atrioventricular node: an unexpected finding in an explanted heart
G Sharma, MD Linden, DS Schultz, KV Inamdar
Cardiovascular Pathology 19 (3), e75-e78, 2010
172010
Aurora-A kinase nuclear expression in chronic lymphocytic leukemia
KV Inamdar, S O'brien, S Sen, M Keating, MH Nguyen, X Wang, ...
Modern Pathology 21 (12), 1428-1435, 2008
172008
Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
C Murga-Zamalloa, A Polk, W Hanel, P Chowdhury, N Brown, AC Hristov, ...
Oncotarget 8 (70), 114474, 2017
162017
The role of aurora A and polo-like kinases in high-risk lymphomas
C Murga-Zamalloa, KV Inamdar, RA Wilcox
Blood Advances 3 (11), 1778-1787, 2019
152019
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
X Geng, C Wang, X Gao, P Chowdhury, J Weiss, JA Villegas, B Saed, ...
Blood Cancer Journal 12 (11), 149, 2022
122022
The system can't perform the operation now. Try again later.
Articles 1–20